Lactobacillus brevis G-101 ameliorates colitis in mice by inhibiting NF-κB, MAPK and AKT pathways and by polarizing M1 macrophages to M2-like macrophages

Journal Article Lactobacillus brevis G‐101 ameliorates colitis in mice by inhibiting NF‐κB, MAPK and AKT pathways and by polarizing M1 macrophages to M2‐like macrophages Get access S.‐E. Jang, S.‐E. Jang Department of Pharmacy College of Pharmacy, Kyung Hee University Seoul KoreaDepartment of Food and Nutrition Kyung Hee University Seoul Korea Search for other works by this author on: Oxford Academic Google Scholar S.R. Hyam, S.R. Hyam Department of Pharmacy College of Pharmacy, Kyung Hee University Seoul Korea Search for other works by this author on: Oxford Academic Google Scholar M.J. Han, M.J. Han Department of Food and Nutrition Kyung Hee University Seoul Korea Search for other works by this author on: Oxford Academic Google Scholar S.‐Y. Kim, S.‐Y. Kim R&D center, CTOBIO Inc. Gyeonggi‐do Korea Search for other works by this author on: Oxford Academic Google Scholar B.‐G. Lee, B.‐G. Lee R&D center, CTOBIO Inc. Gyeonggi‐do Korea Search for other works by this author on: Oxford Academic Google Scholar D.‐H. Kim D.‐H. Kim Department of Pharmacy College of Pharmacy, Kyung Hee University Seoul Korea Correspondence Dong‐Hyun Kim, Departments of Life and Nanopharmaceutical Sciences and Pharmaceutical Science, College of Pharmacy, Kyung Hee University, 1, Hoegi, Dongdaemun‐ku, Seoul 130‐701, Korea. E‐mail dhkim@khu.ac.kr Search for other works by this author on: Oxford Academic Google Scholar Journal of Applied Microbiology, Volume 115, Issue 3, 1 September 2013, Pages 888–896, https://doi.org/10.1111/jam.12273 Published: 01 September 2013 Article history Received: 05 March 2013 Revision received: 28 May 2013 Accepted: 31 May 2013 Published: 01 September 2013